Evidence map›Paper›PMID 26535188›Full record

ArticleTranslational medicine @ UniSa

Role of Nitric Oxide in Glioblastoma Therapy: Another Step to Resolve the Terrible Puzzle ?

R Altieri, M Fontanella, A Agnoletti, P P Panciani, G Spena, E Crobeddu, G Pilloni, V Tardivo, M Lanotte, F Zenga and 2 more

Open access · greenAbstract read
In one paragraph

Article in Translational medicine @ UniSa. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  11. miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

R AltieriDepartment of Neurosurgery, University of Turin, Italy.
M FontanellaDepartment of Neurosurgery of Brescia, Italy.
A AgnolettiDepartment of Neurosurgery, University of Turin, Italy.
P P PancianiDepartment of Neurosurgery of Brescia, Italy.
G SpenaDepartment of Neurosurgery of Brescia, Italy.
E CrobedduDepartment of Neurosurgery, University of Turin, Italy.
G PilloniDepartment of Neurosurgery, University of Turin, Italy.
V TardivoDepartment of Neurosurgery, University of Turin, Italy.
M LanotteDepartment of Neurosurgery, University of Turin, Italy.
F ZengaDepartment of Neurosurgery, University of Turin, Italy.
A DucatiDepartment of Neurosurgery, University of Turin, Italy.
D GarbossaDepartment of Neurosurgery, University of Turin, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma Multiforme, the most common and aggressive primary brain tumor, remains incurable despite of the advent of modern surgical and medical treatments. This poor prognosis depends by the recurrence after surgery and intrinsic or acquired resistance to chemotherapy and radiotherapy. Nitric oxide is a small molecule that plays a key roles in glioma pathophysiology. Many researches showing that NO is involved in induction of apoptosis, radiosensitization and chemosensitization. Therefore, NO role, if clarified, may improve the knowledge about this unsolved puzzle called GBM.

Indexed as

ChemotherapyGlioblastomaGliomaNitric OxideNO synthasesRadiotheraypy

Identifiers

PMID26535188
PMCPMC4592044
OpenAlexW2190282533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.